The histone methyltransferase SMYD2 is a novel therapeutic target for the induction of apoptosis in ovarian clear cell carcinoma cells

Previous studies have suggested that histone methylation can modulate carcinogenesis and cancer progression. For instance, the histone methyltransferase SET and MYND domain containing 2 (SMYD2) is overexpressed in several types of cancer tissue. The aim of the present study was to determine whether...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncol Lett
Asıl Yazarlar: Kojima, Machiko, Sone, Kenbun, Oda, Katsutoshi, Hamamoto, Ryuji, Kaneko, Syuzo, Oki, Shinya, Kukita, Asako, Kawata, Akira, Honjoh, Harunori, Kawata, Yoshiko, Kashiyama, Tomoko, Sato, Masakazu, Taguchi, Ayumi, Miyamoto, Yuichiro, Tanikawa, Michihiro, Tsuruga, Tetsushi, Nagasaka, Kazunori, Wada-Hiraike, Osamu, Osuga, Yutaka, Fujii, Tomoyuki
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: D.A. Spandidos 2020
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7471656/
https://ncbi.nlm.nih.gov/pubmed/32934721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.12014
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller